CRISPR
Zug, CH · Founded 2013 · 343 employees on LinkedIn · 6 known investors
CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.
Founders & leadership
CRISPR was founded in 2013 by Emmanuelle Charpentier.
Investors · 6
Avoro Capital AdvisorsNew York
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
AbingworthreportedLondon · $15M – $30M
Versant VenturesreportedSan Francisco · $250K – $5M
Also in the syndicate · 2
Spectrum ImpactleadVijay Alreja Family Office
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Series A roundNov 2025
Spectrum Impact (lead), Vijay Alreja Family Office
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through CRISPR went on to found or lead other companies.
In the news
Why CRISPR Therapeutics Stock Rocked the Market Last Month - AOLaol.com · Sep 2026Frequently asked questions
- What does CRISPR do?
- CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.
- Who founded CRISPR?
- CRISPR was founded by Emmanuelle Charpentier in 2013.
- Who are CRISPR's investors?
- CRISPR's investors include Avoro Capital Advisors, New Enterprise Associates (NEA), Abingworth, Versant Ventures.
- Where is CRISPR headquartered?
- CRISPR is headquartered in Zug, CH.